58573-94-7Relevant articles and documents
COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS
-
Page/Page column 59, (2008/06/13)
Disclosed herein are novel compounds with activity at RARβ 2 receptors. Further disclosed are the use of such compounds for treatment of or to alleviate symptoms of cancer, neurological disorders such as memory deficits and schizophrenia, neurodegenerative disorders such as Parkinson's and Alzheimer's diseases, inflammatory disorders such as psoriasis and rheumatoid arthritis, eye disorders and depression.
Liquid crystal compound
-
, (2008/06/13)
A liquid crystal compound represented by the following general formula: wherein R* stands for an alkyl group having an asymmetric carbon atom, R stands for a linear alkyl group, and A stands for STR1
Biphenyl esters and liquid crystalline mixtures comprising them
-
, (2008/06/13)
Biphenyl esters of the formula STR1 wherein X is --CO--O-- or --O--CO-- and R1 and R2 each are alkyl or alkoxy of 1 - 8 carbon atoms, enlarge significantly the temperature range of the nematic phase of liquid-crystalline compositions without adversely affecting other properties.